MFIM
ADMA icon

Mesirow Financial Investment Management’s ADMA Biologics ADMA Stock Holding History

Mesirow Financial Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,662
Closed -$633K – 537
2025
Q1 		$633K Hold
30,662
– – 0.01% 321
2024
Q4 		$526K Buy
30,662
+215
+0.7% +$4.04K 0.01% 346
2024
Q3 		$609K Buy
+30,447
New +$473K 0.01% 333
2024
Q1 		– Sell
-78,605
Closed -$376K – 526
2023
Q4 		$376K Buy
78,605
+5,928
+8% +$21.9K 0.01% 367
2023
Q3 		$260K Buy
72,677
+20,991
+41% +$80.8K 1.13% 49
2023
Q2 		$191K Buy
+51,686
New +$192K 0.81% 74

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Mesirow Financial Investment Management's ADMA Position: Q2 2025 in Review

Mesirow Financial Investment Management sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 30,662 shares — an estimated $633K sold.

Mesirow Financial Investment Management first reported a position in ADMA in Q2 2023 and held it in 6 quarters. The position peaked at $633K in Q1 2025. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

  • Mesirow Financial Investment Management reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 30,662 ADMA Biologics shares in Q2 2025, an estimated $633K.
  • Mesirow Financial Investment Management first reported a position in ADMA Biologics in Q2 2023 and held it in 6 quarters.
  • Mesirow Financial Investment Management's ADMA Biologics position peaked at $633K in Q1 2025.
  • 368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2025, filed 4 Aug 2025.